Cancer screening in a high risk population: A clinical trial

Ultrasound in Medicine and Biology

Volumn 27, Issue 4, 2001, Pages 461-466

  Taylor, Kenneth J W ^a   Schwartz, Peter E ^b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Breast neoplasms; CA 125; Ovarian cancer screening; Ultrasound Doppler studies

Indexed keywords

MAMMOGRAPHY; SURGERY; ULTRASONICS;

CANCER SCREENING;

TUMORS;

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OVARY CANCER; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; ULTRASOUND;

ADULT; BLOOD FLOW VELOCITY; CA-125 ANTIGEN; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY, DOPPLER; UTERINE NEOPLASMS;

EID: 0035006199     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-5629(00)00359-8     Document Type: Article

References (24)

1. Boyd J., Rubin S.C. Hereditary ovarian cancer Molecular genetics and clinical implications . Gynecol Oncol. 64:1997;196-206.
2. Burke W., Daly M., Garber J., et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCAI and BRCA2. Cancer Genetics Studies Consortium. JAMA. 277:1997;997-1003.
3. Carter J.R., Lau M., Fowler J.M., et al. Blood flow characteristics of ovarian tumors Implications for ovarian cancer screening . Am J Obstet Gynecol. 172:1995;901-907.
4. Cohen C.J., Jennings T.S. Screening for ovarian cancer The role of noninvasive imaging techniques . Am J Obstet Gynecol. 170:1994;1088-1094.
5. DePriest P.D., Gallion H.H., Pavlik E.J., Kryscio R.J., Van Nagell J.R. Transvaginal sonogrpahy as a screening method for the detection of early ovarian cancer. Gynecol Oncol. 65:1997;408-414.
6. Einhorn N., Sjovall K., Knapp R.C., et al. Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol. 80:1992;14-18.
7. Greenlee R.T., Murray T., Bolden S., Wingo P.A. Cancer statistics 2000. CA Cancer J Clin. 50:2000;7-33.
8. Grover S.R., Quinn M.A. Is there any value in bimanual pelvic examination as a screening test. Med J Aust. 162:1995;408-410.
9. Houlston R., Bourne T.H., Davies A., et al. Use of family history in a screening clinic for familial ovarian cancer. Gynecol Oncol. 47:1992;247-252.
10. Jacobs I.J., Skates S., Davies A.P., et al. Risk of diagnosis of ovarian cancer after raised serum CA125 concentration A prospective cohort study . Br Med J. 313:1996;1355-1358.
11. Karlen BY, Baldwin RL, Lopez-Luevanos E. Peritoneal serous papillary carcinoma; A phenotypic variant of familial ovarian cancer: Implications for ovarian cancer screening.Proceedings of the American Gynecology and Obstetrics Society, Hot Springs, VA, Sept 3-5.1998:46-47.
12. Lynch H.T., Lynch J.F. The Lynch syndrome. Curr Opin Oncol. 5:1993;687-696.
13. Lynch H.T., Lemon S.J., Durham C., et al. A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer. 79:1997;2219-2228.
14. Consensus Development Panel on Ovarian Cancer conference on ovarian cancer.Screening, treatment, and follow-up. JAMA. 273:1995;491-497.
15. Piver M.S., Jishi M.F., Tsukada Y., Nava G. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. Report of the Gilda Radner Familial Ovarian Registry. Cancer. 71:1993;2751-2755.
16. Schwartz P.E. Prophylactic oophorectomy for the prevention of epithelial ovarian cancer revisited. Eur J Menopause. 4:1997;105-115.
17. Schwartz P.E., Chambers J.T., Taylor K.J., Pellerito J., et al. Early detection of ovarian cancer Backbround, rationale, and structure of the Yale Early Detection Program . Yale J Biol Med. 64:1991;557-571.
18. Struewing J.P., Watson P., Easton D.F., et al. Prophylactic oophorectomy in inherited breast/ovarian cancer families. J Natl Cancer Inst Monogr. 17:1995;33-35.
19. Surveillance, Epidemiology, and End Results (SEER). Am Cancer Society, Facts, and Figures Atlanta, GA: American Cancer Society, 1994.
20. Taylor KJW. Doppler ultrasound derived indices in screening and diagnosis of ovarian cancer. In: Hudson C, ed. Ovarian cancer 3. Oxford University Press, 2000 (in press).
21. Taylor KJW, Scoutt LM, Brown JM, Hammers LW, Quedens-Case C. Postmenopausal ovaries: A re-evaluation of normal size as a function age. Radiology 1997;205(P):497.
22. Troiano R.N., Quedans-Case C., Taylor K.J.W. Correlation of findings on transvaginal sonography with serum Ca125 levels. Am J Roentgenol. 168:1997;1587-1590.
23. Van Nagel J.R., Gallion H.H., Pavlik E.J., DePriest P.D. Ovarian cancer screening. Cancer. 76:1995;2086-2091.
24. Young R.C., Walton L.A., Ellenberg S.S., et al. Adjuvant therapy in Stage I and Stage II epithelial ovarian cancer. Results of two prospective, randomized trials. N Engl J Med. 322:1990;1021-1027.